Leukemia Clinical Research Foundation
Nonprofit profile at a glance
- EIN
- 411586846
- IRS 990-EZ coverage
- 2024–2024
- Forms available
- Form 990 2023, Form 990-EZ 2024
- Location
- St Paul, MN, USA
- Phone
- 6123083126
- Rating confidence
- Limited
Reported finances
- Revenue
- $0
- Assets
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
3 people listed
Executive titles in this filing
- Dr Michael Caligiuri (President)
People named in this filing
- Dr Michael Caligiuri (President)
- Kenneth D Rowe (Treasurer)
- Dr Hartmut Doehner (Board Member)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To provide much needed financial assistance for clinical research in adult leukemia and lymphomas.
What it reported doing in 2024
The foundation's purposes is to engage in, assist and contribute to the support of charitable, scientific or educational activities and projects including, but not limited to, clinical research and the study of adult leukemia and lymphomas for the purposes of furthering understanding and treatment of these disorders. For these purposes, the foundation awarded grants totalling $15,000 during the current year
Operating model
- Revenue model
- Cannot be determined from the filing. The filing does not provide enough consistent revenue detail to tell how this nonprofit funds its work.
- Distribution model
- Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: NotEnoughData
- Transparency & Controls: 74
- Sustainability: NotEnoughData
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: Limited
Transparency & Controls
- Consistency checks: 90%; rating input score 90; 2nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: Limited
- Total-asset coverage ratio: Limited
- Liabilities to assets ratio: Limited
- Officer compensation ratio: Limited
Growth
- Program expense growth: Limited
- Revenue growth: -15.2% per year; rating input score 0; 18th percentile among comparable filings
- Asset growth: -12.2% per year; rating input score 0; 15th percentile among comparable filings
Details
- Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment
- Leadership: top reported pay $0 · 3 people listed
- Consistency: 1 of 2 current checks pass · 1 finding to review
- Schedules: 2 filed schedules
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- Moderate — Transparency & Controls: Part I part ii net assets crosscheck did not reconcile in the filed values.
- High — Growth: Revenue growth scored 0/100.
- High — Growth: Asset growth scored 0/100.